Literature DB >> 20179248

Mice deficient in group VIB phospholipase A2 (iPLA2gamma) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet.

Haowei Song1, Mary Wohltmann, Shunzhong Bao, Jack H Ladenson, Clay F Semenkovich, John Turk.   

Abstract

Phospholipases A(2) (PLA(2)) play important roles in metabolic processes, and the Group VI PLA(2) family is comprised of intracellular enzymes that do not require Ca(2+) for catalysis. Mice deficient in Group VIA PLA(2) (iPLA(2)beta) develop more severe glucose intolerance than wild-type (WT) mice in response to dietary stress. Group VIB PLA(2) (iPLA(2)gamma) is a related enzyme distributed in membranous organelles, including mitochondria, and iPLA(2)gamma knockout (KO) mice exhibit altered mitochondrial morphology and function. We have compared metabolic responses of iPLA(2)gamma-KO and WT mice fed a Western diet (WD) with a high fat content. We find that KO mice are resistant to WD-induced increases in body weight and adiposity and in blood levels of cholesterol, glucose, and insulin, even though WT and KO mice exhibit similar food consumption and dietary fat digestion and absorption. KO mice are also relatively resistant to WD-induced insulin resistance, glucose intolerance, and altered patterns of fat vs. carbohydrate fuel utilization. KO skeletal muscle exhibits impaired mitochondrial beta-oxidation of fatty acids, as reflected by accumulation of larger amounts of long-chain acylcarnitine (LCAC) species in KO muscle and liver compared with WT in response to WD feeding. This is associated with increased urinary excretion of LCAC and much reduced deposition of triacylglycerols in liver by WD-fed KO compared with WT mice. The iPLA(2)gamma-deficient genotype thus results in a phenotype characterized by impaired mitochondrial oxidation of fatty acids and relative resistance to the metabolic abnormalities induced by WD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179248      PMCID: PMC2886524          DOI: 10.1152/ajpendo.00780.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  83 in total

1.  U bodies are cytoplasmic structures that contain uridine-rich small nuclear ribonucleoproteins and associate with P bodies.

Authors:  Ji-Long Liu; Joseph G Gall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-26       Impact factor: 11.205

2.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Authors:  Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

3.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

4.  Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.

Authors:  J Andrew Pospisilik; Claude Knauf; Nicholas Joza; Paule Benit; Michael Orthofer; Patrice D Cani; Ingo Ebersberger; Tomoki Nakashima; Renu Sarao; Gregory Neely; Harald Esterbauer; Andrey Kozlov; C Ronald Kahn; Guido Kroemer; Pierre Rustin; Remy Burcelin; Josef M Penninger
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

5.  Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype.

Authors:  David J Mancuso; Harold F Sims; Xianlin Han; Christopher M Jenkins; Shao Ping Guan; Kui Yang; Sung Ho Moon; Terri Pietka; Nada A Abumrad; Paul H Schlesinger; Richard W Gross
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

6.  Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2007-07-05       Impact factor: 5.157

7.  Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2.

Authors:  Shunzhong Bao; Yankun Li; Xiaoyong Lei; Mary Wohltmann; Wu Jin; Alan Bohrer; Clay F Semenkovich; Sasanka Ramanadham; Ira Tabas; John Turk
Journal:  J Biol Chem       Date:  2007-07-12       Impact factor: 5.157

8.  Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis.

Authors:  Manu V Chakravarthy; Yimin Zhu; Miguel López; Li Yin; David F Wozniak; Trey Coleman; Zhiyuan Hu; Michael Wolfgang; Antonio Vidal-Puig; M Daniel Lane; Clay F Semenkovich
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 9.  Selective versus total insulin resistance: a pathogenic paradox.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

10.  Hsp90 inhibition decreases mitochondrial protein turnover.

Authors:  Daciana H Margineantu; Christine B Emerson; Dolores Diaz; David M Hockenbery
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

View more
  22 in total

1.  Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse.

Authors:  Janhavi Sharma; John Turk; Jane McHowat
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

Review 2.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

3.  Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

Authors:  Myoung Sook Han; Yu-Mi Lim; Wenying Quan; Jung Ran Kim; Kun Wook Chung; Mira Kang; Sunshin Kim; Sun Young Park; Joong-Soo Han; Shin-Young Park; Hyae Gyeong Cheon; Sang Dal Rhee; Tae-Sik Park; Myung-Shik Lee
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

Review 4.  Reign in the membrane: How common lipids govern mitochondrial function.

Authors:  Katsuhiko Funai; Scott A Summers; Jared Rutter
Journal:  Curr Opin Cell Biol       Date:  2020-02-24       Impact factor: 8.382

5.  Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation.

Authors:  David J Mancuso; Harold F Sims; Kui Yang; Michael A Kiebish; Xiong Su; Christopher M Jenkins; Shaoping Guan; Sung Ho Moon; Terri Pietka; Fatiha Nassir; Timothy Schappe; Kristin Moore; Xianlin Han; Nada A Abumrad; Richard W Gross
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

6.  Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling.

Authors:  Haowei Song; Mary Wohltmann; Min Tan; Shunzhong Bao; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

7.  High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice.

Authors:  Mayumi Yamato; Takeshi Shiba; Tomomi Ide; Naoko Seri; Wataru Kudo; Makoto Ando; Ken-ichi Yamada; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Mol Cell Biochem       Date:  2011-08-18       Impact factor: 3.396

Review 8.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

9.  Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation.

Authors:  Anthony Drecourt; Joël Babdor; Michael Dussiot; Floriane Petit; Nicolas Goudin; Meriem Garfa-Traoré; Florence Habarou; Christine Bole-Feysot; Patrick Nitschké; Chris Ottolenghi; Metodi D Metodiev; Valérie Serre; Isabelle Desguerre; Nathalie Boddaert; Olivier Hermine; Arnold Munnich; Agnès Rötig
Journal:  Am J Hum Genet       Date:  2018-02-01       Impact factor: 11.025

10.  Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.

Authors:  Ying Liu; Sanjana Sen; Sivaporn Wannaiampikul; Rengasamy Palanivel; Ruby L C Hoo; Ruth Isserlin; Gary D Bader; Rungsunn Tungtrongchitr; Yves Deshaies; Aimin Xu; Gary Sweeney
Journal:  Biochem J       Date:  2015-04-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.